Could Fresh Global Outbreaks Move the Needle for Moderna?

As several parts of the world struggle with Covid-19 surges, MRNA could win in the long war against the pandemic.

Is It Safe to Climb Back Aboard the ARKK? Let's Check the Chart

ARK Innovation ETF offered a glimmer of technical hope Thursday to those following the high-growth space, plus we look at two new stocks.

GoodRx Doesn't Look So Good

Here's what it's going to take to turn the charts positive.

Bausch Health Can't Seem to Pass Its Chart Exam as Earnings Approach

Here's what the charts show for BHC as the name prepares to post earnings on Wednesday.

Centene Has Made a Top So Become a Seller

Here's what trades should do.

CVS Health Reports Q4 Results: Here's How I'm Trading the Shares

Following earnings Wednesday morning, there's going to be some profit taking.

Let's See If CVS's Charts Look Healthy Ahead of Earnings

Here's what traders should do now.

How's UnitedHealth Group Doing in This Weak Market Environment?

Here's how to play it now.

Viagra to Vaccines: 8 Healthcare Favorites for 2022

Investment experts pick their favorites in the sector for 2022, ranging from diagnostics to medical devices and medical marijuana to drug development.

Is it Time to Believe in a Value Rotation?

Questions about the staying power of the present market turn are crucial for portfolio positioning.